Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Virtual Reality and Mental Practice for Balance and Walking in Multiple Sclerosis

Compares virtual reality training and mental practice for balance and walking in multiple sclerosis.

Plain-language title generated from the registry record
Registry title: Virtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple Sclerosis

Key facts

Where
Giza, EgyptSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 35 years old?

Source: NCT07918339, who can take part

Where in Egypt

  • Faculty of Physical Therapy, Cairo UniversityGiza, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Cairo University
Trial code
NCT07918339
Record updated
5 November 2026
Original description
This study is conducted to:Read full original descriptionShow less

Virtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple Sclerosis

This study is conducted to:

* Investigate the effect of virtual reality based training on balance and risk of falling. * Investigate the effect of virtual reality based training on gait. * Investigate the effect of mental practice on balance and risk of falling. * Investigate the effect of mental practice on gait. * Compare between the effect of virtual reality based training and mental practice on balance and gait

Inclusion: Patients with RRMS; Patient's age will be range from 20 - 35 years; Patients are able to walk 10 meter with or without assistance; Patients with ≤ 6 according to an Expanded Disability Status Scale (EDSS); Patients are cognitively able to follow instructions; Patient's body mass index (BMI) will be ranged from 18.5 to 29.99 Kg/m2.

Exclusion: History of epilepsy or motion sickness with VR; Patients with MS relapse in the last 30 days; Visual impairments interfering with VR; Severe spasticity or orthopaedic deformity; Recent musculoskeletal injury.

ClinicalTrials.gov NCT07918339